Altamira Therapeutics Ltd. Number Of Share Options Granted In Share-based Payment Arrangement
Altamira Therapeutics Ltd. (CYTOF) reported Number Of Share Options Granted In Share-based Payment Arrangement of 103357900.00% for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement · last filed 2025-04-30
shares
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|
| 2018-12-31 | 911.98K shares 20-F · filed 2019-03-14 |
| 2017-12-31 | 1.92M shares 20-F · filed 2018-03-22 |
| 2016-12-31 | 555.66K shares 20-F · filed 2018-03-22 |
pure
| Period end | Number Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|
| 2024-12-31 | 103357900.00% 20-F · filed 2025-04-30 |
| 2023-12-31 | 13890700.00% 20-F · filed 2025-04-30 |